BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1319 related articles for article (PubMed ID: 17070580)

  • 1. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study.
    Iwase A; Suzuki Y; Araie M; Yamamoto T; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G; Inoue Y; Kitazawa Y;
    Ophthalmology; 2004 Sep; 111(9):1641-8. PubMed ID: 15350316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
    Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
    Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of frequency doubling perimetry in glaucoma screening of aged 40 or more population].
    Li JJ; Xu L; Zhang RX; Sun XY; Yang H; Zou Y; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2005 Mar; 41(3):221-5. PubMed ID: 15840362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
    Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
    J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
    Horn FK; Wakili N; Jünemann AM; Korth M
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
    Realini T; Lai MQ; Barber L
    Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cataract on the results of frequency-doubling technology perimetry.
    Tanna AP; Abraham C; Lai J; Shen J
    Ophthalmology; 2004 Aug; 111(8):1504-7. PubMed ID: 15288979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma.
    Liu S; Lam S; Weinreb RN; Ye C; Cheung CY; Lai G; Lam DS; Leung CK
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7325-31. PubMed ID: 21810975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humphrey matrix frequency doubling perimetry for detection of visual-field defects in open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham S
    Br J Ophthalmol; 2009 May; 93(5):582-8. PubMed ID: 18669543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals.
    Pierre-Filho Pde T; Schimiti RB; de Vasconcellos JP; Costa VP
    Acta Ophthalmol Scand; 2006 Jun; 84(3):345-50. PubMed ID: 16704696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of false positives with the Humphrey Field Analyzer II perimeter with the SITA Algorithm.
    Newkirk MR; Gardiner SK; Demirel S; Johnson CA
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4632-7. PubMed ID: 17003461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humphrey matrix frequency doubling technology perimetry and optical coherence tomography measurement of the retinal nerve fiber layer thickness in both normal and ocular hypertensive subjects.
    Mastropasqua L; Brusini P; Carpineto P; Ciancaglini M; Di Antonio L; Zeppieri MW; Parisi L
    J Glaucoma; 2006 Aug; 15(4):328-35. PubMed ID: 16865011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
    Bozkurt B; Yilmaz PT; Irkec M
    J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry.
    Wall M; Neahring RK; Woodward KR
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1277-83. PubMed ID: 11923276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.